[ad_1] Top-Line Results from 6-month double-blind Phase 2b PARADIGM trial with NeuroSense’s lead drug candidate for ALS, PrimeC, include: PrimeC achieved primary safety and tolerability endpoints with a safety and…
Tag: Efficacy
Post Hoc Analysis Showed CIMZIA® (Certolizumab Pegol) Resulted in Meaningful Efficacy for RA Patients with High Levels of Rheumatoid Factor (RF)
[ad_1] A post hoc analysis from the EXXELERATE Phase 4 trial showed that 65.7 percent of CIMZIA-treated patients with rheumatoid arthritis (RA) and high rheumatoid factor (RF) levels achieved low…
Oncolytics Announces the Anal Cancer Cohort of the GOBLET Phase 1/2 Study of Pelareorep and Atezolizumab Has Met the Success Criteria for Efficacy
[ad_1] Pelareorep-atezolizumab combination data exceeds historical control trials with a 37.5% objective response rate, including a complete response SAN DIEGO and CALGARY, Alberta, Nov. 9, 2023 /PRNewswire/ — Oncolytics Biotech® Inc.…
Expert Views: Pfizer ends COVID-19 trial with 95% efficacy
[ad_1] (Reuters) – Pfizer Inc said on Wednesday that final results from the late-stage trial of its COVID-19 vaccine showed it was 95% effective, adding it had the required two-months…
Singapore eco-advocates question efficacy of supermarkets’ ‘honour’-based plastic bag charge
[ad_1] Such honesty schemes are being used by major operators such as NTUC FairPrice, which has over 100 stores islandwide, DFI Retail Group, which has 75 supermarkets under the Cold Storage and Giant brands,…
The remarkable efficacy of organisational change networks
[ad_1] UNITED STATES I was recently reminded of the most cited article in my academic field, sociologist Mark S Granovetter’s 1973 “The Strength of Weak Ties”. The occasion was a…
Ukraine Resumes Electricity Exports, as Russian Strikes on Grid Lose Efficacy
[ad_1] Ukraine’s decision to resume electricity exports signals that the country has withstood months of Russian attacks on civilian infrastructure A worker walks through a missile-damaged electricity substation that supplies…
LEO Pharma Presents Late-Breaking Positive Phase 2a Efficacy and Safety Results of LEO 138559 in Moderate-to-Severe Atopic Dermatitis at the 2023 AAD Annual Meeting
[ad_1] Results presented at AAD 2023 demonstrated that investigational agent LEO 138559 met its primary endpoint of change in the Eczema Area and Severity Index (EASI) compared with placebo1 Efficacy…